Patents Assigned to Labrys Biologics, Inc.
-
Publication number: 20170037117Abstract: The disclosure features compositions and methods for treating a metabolic disorder, including diabetes, conditions associated with inhibition of insulin secretion, or for increasing longevity. In some embodiments, the methods comprise administering an anti-CGRP antagonist antibody.Type: ApplicationFiled: October 11, 2016Publication date: February 9, 2017Applicants: Salk Institute for Biological Studies, The Regents of the University of California, Labrys Biologics, Inc.Inventors: Andrew Dillin, Celine Riera, Corey Goodman
-
Patent number: 9365648Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.Type: GrantFiled: February 16, 2016Date of Patent: June 14, 2016Assignee: LABRYS BIOLOGICS, INC.Inventors: Joerg Zeller, Kristian T. Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Jones Collier, Arnon Rosenthal
-
Patent number: 9346881Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.Type: GrantFiled: August 31, 2015Date of Patent: May 24, 2016Assignee: LABRYS BIOLOGICS, INC.Inventors: Joerg Zeller, Kristian T. Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Jones Collier, Arnon Rosenthal
-
Patent number: 9340614Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.Type: GrantFiled: August 31, 2015Date of Patent: May 17, 2016Assignee: LABRYS BIOLOGICS, INC.Inventors: Joerg Zeller, Kristian T. Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Jones Collier, Arnon Rosenthal
-
Patent number: 9328168Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.Type: GrantFiled: May 21, 2015Date of Patent: May 3, 2016Assignee: LABRYS BIOLOGICS, INC.Inventors: Joerg Zeller, Kristian T. Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Jones Collier, Arnon Rosenthal
-
Patent number: 9328167Abstract: The invention relates to an anti-CGRP antibody for use in the prevention and/or treatment of chronic pain and/or symptoms of chronic pain, and to a method of treating and/or preventing chronic pain and/or symptoms of chronic pain using an anti-CGRP antibody.Type: GrantFiled: February 2, 2015Date of Patent: May 3, 2016Assignee: LABRYS BIOLOGICS, INC.Inventors: Kristian Todd Poulsen, David Louis Shelton, Joerg Zeller, Ian Machin, Laura Corradini
-
Patent number: 9279018Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.Type: GrantFiled: August 31, 2015Date of Patent: March 8, 2016Assignee: LABRYS BIOLOGICS, INC.Inventors: Joerg Zeller, Kristian T. Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Jones Collier, Arnon Rosenthal
-
Patent number: 9266951Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.Type: GrantFiled: August 31, 2015Date of Patent: February 23, 2016Assignee: LABRYS BIOLOGICS, INC.Inventors: Joerg Zeller, Kristian T. Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Jones Collier, Arnon Rosenthal
-
Patent number: 9115194Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.Type: GrantFiled: April 14, 2014Date of Patent: August 25, 2015Assignee: Labrys Biologics, Inc.Inventors: Joerg Zeller, Kristian T. Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Jones Collier, Arnon Rosenthal
-
Publication number: 20140314767Abstract: The invention features methods for preventing or treating visceral pain, including pain associated with functional bowel disorder, inflammatory bowel disease and interstitial cystitis, by administering an anti-CGRP antagonist antibody.Type: ApplicationFiled: October 18, 2013Publication date: October 23, 2014Applicant: Labrys Biologics, Inc.Inventors: Ariel Ates Pios, Kristian Todd Poulsen, David Louis Shelton, Joerg Zeller
-
Publication number: 20140308290Abstract: The invention features methods for preventing or treating visceral pain, including pain associated with functional bowel disorder, inflammatory bowel disease and interstitial cystitis, by administering an anti-CGRP antagonist antibody.Type: ApplicationFiled: June 4, 2014Publication date: October 16, 2014Applicant: Labrys Biologics, Inc.Inventors: Ariel Ates Pios, Kristian Todd Poulsen, David Louis Shelton, Joerg Zeller
-
Publication number: 20140147438Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.Type: ApplicationFiled: November 21, 2013Publication date: May 29, 2014Applicant: LABRYS BIOLOGICS, INC.Inventors: JOERG ZELLER, KRISTIAN T. POULSEN, YASMINA NOUBIA ABDICHE, JAUME PONS, SIERRA JONES COLLIER, ARNON ROSENTHAL
-
Patent number: 8734802Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.Type: GrantFiled: November 21, 2013Date of Patent: May 27, 2014Assignee: Labrys Biologics, Inc.Inventors: Joerg Zeller, Kristian T. Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Jones Collier, Arnon Rosenthal
-
Patent number: 8623366Abstract: The invention features methods for preventing or treating visceral pain, including pain associated with functional bowel disorder, inflammatory bowel disease and interstitial cystitis, by administering an anti-CGRP antagonist antibody.Type: GrantFiled: August 23, 2010Date of Patent: January 7, 2014Assignee: Labrys Biologics, Inc.Inventors: Ariel Ates Pios, Kristian Todd Poulsen, David Louis Shelton, Joerg Zeller
-
Patent number: 8597649Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.Type: GrantFiled: April 25, 2013Date of Patent: December 3, 2013Assignee: Labrys Biologics, Inc.Inventors: Joerg Zeller, Kristian T. Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Jones Collier, Arnon Rosenthal
-
Patent number: 8586045Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.Type: GrantFiled: July 11, 2011Date of Patent: November 19, 2013Assignee: Labrys Biologics, Inc.Inventors: Joerg Zeller, Kristian T. Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Lee Jones Collier, Arnon Rosenthal
-
Publication number: 20130216535Abstract: The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.Type: ApplicationFiled: April 25, 2013Publication date: August 22, 2013Applicant: Labrys Biologics, Inc.Inventor: Labrys Biologics, Inc.